Abstract:Objective The present paper is designed to study whether the heparanase eptitopes elicit heparanase-specific CTL against various tumors in vitro and provide theoretical evidence for their clinical application.Methods Dendritic cells(DCs) were pulsed with five HLA-A2-restricted epitopes of heparanase respectively to induce heparanase-specific cytotoxic T lymphocytes(CTLs).Specific lysis to various tumor cell lines was examined by a 4 h standard 51 Cr release assay.The IFN-γ releasing of effector cells was tested by ELISPOT.Results Of the five epitopes of heparanase,only Hpa(525-533),Hpa(277-285) and Hpa(405-413) could elicit potent specific lysis to KATO-Ⅲ,U2OS and SW480 cells which were heparanase and HLA-A2 positive.Effector induced by the above epitopes could not only lyse MCF-7 cells,which was heparanase negative,But also lyse as HepG2 cells,which was HLA-A2 negaive.But the specific lysis reoccurred after MCF-7 cells transduced with a plasmid contained full-length cDNA of heparanase or HepG2 cells transduced with a plasmid contained full-length cDNA of HLA-A2.Futher study demonstrated these heparanase-specific effectors induced by the above epitopes could not lyse autologous lymphocytes.In addition,we also found that Hpa(525-533),Hpa(277-285) and Hpa(405-413) heparanase epitopes could increase IFN-γ releasing of effectors.Conclusions The above studies show for the first time that the heparanase epitopes Hpa(525-533),Hpa(277-285) and Hpa(405-413) are capable of eliciting a specific anti-tumor immune response by heparanase-specific CTLs,as well as a non-specific anti-tumor immune response by enhancing cytokines releasing.These findings show that heparanase epitope vaccines have various advantages such as broad-spectrum,high-effect,high specificity and safety,which will provide theoretical evidence for their clinical application.

HLA-A2–Restricted Cytotoxic T Lymphocyte Epitopes from Human Heparanase as Novel Targets for Broad-Spectrum Tumor Immunotherapy

Cytotoxic T Lymphocyte Epitopes from Human Heparanase Can Elicit a Potent Anti-Tumor Immune Response in Mice

Identification of predicted epitopes of HLA-A * 0201-restricted cytotoxic T lymphocytes derived from human papillomavirus type 11 E7 antigen

Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors.

A Modified HLA-A*0201-restricted CTL Epitope from Human Oncoprotein (hpebp4) Induces More Efficient Antitumor Responses

H-2k(B)-Restricted Ctl Epitopes From Mouse Heparanase Elicit An Antitumor Immune Response In Vivo

Heparanase Epitope Peptide-Pulsed DCs Elicit Immune Responses Against Various Tumors in Vitro

In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapy

Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587.

Prediction, Synthesis and Identification of HLA-A2-restricted Cytotoxic T Lymphocyte Epitopes of the Tumor Antigen MAGE-n

The study of human melanoma-specific antigen peptides by HLA-A2 restricted tumor-infiltrating lymphocytes

Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE

Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A2(+) cancer patients as cancer vaccine

Identification of promiscuous HLA-DR-restricted CD4⁺ T-cell epitopes on the cancer-testis antigen HCA587.

Identification of Melanoma-Specific Peptide Epitopes by HLA-A2.1-restricted Cytotoxic T Lymphocytes.

Identification of Promiscuous HLA‐DR‐restricted CD4+ T‐cell Epitopes on the Cancer‐testis Antigen HCA587

MHC Class II Restricted Neoantigen Peptides Predicted by Clonal Mutation Analysis in Lung Adenocarcinoma Patients: Implications on Prognostic Immunological Biomarker and Vaccine Design.

Myeloid Dendritic Cells Loaded with Dendritic Tandem Multiple Antigenic Telomerase Reverse Transcriptase (htert) Epitope Peptides: A Potentially Promising Tumor Vaccine

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

Identification of a New Cytotoxic T-cell Epitope P675 of Human Telomerase Reverse Transcriptase.

Synthetic Tumor-Specific Antigenic Peptides with a Strong Affinity to HLA-A2 Elicit Anti-Breast Cancer Immune Response Through Activating CD8+ T Cells